ATAI
Price
$1.21
Change
+$0.02 (+1.68%)
Updated
Dec 23, 04:59 PM (EDT)
94 days until earnings call
UDMY
Price
$7.96
Change
+$0.06 (+0.76%)
Updated
Dec 23, 04:59 PM (EDT)
51 days until earnings call
Ad is loading...

ATAI vs UDMY

Header iconATAI vs UDMY Comparison
Open Charts ATAI vs UDMYBanner chart's image
ATAI Life Sciences
Price$1.21
Change+$0.02 (+1.68%)
Volume$5.13K
CapitalizationN/A
Udemy
Price$7.96
Change+$0.06 (+0.76%)
Volume$14.9K
CapitalizationN/A
ATAI vs UDMY Comparison Chart
Loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UDMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATAI vs. UDMY commentary
Dec 24, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATAI is a Hold and UDMY is a Hold.

COMPARISON
Comparison
Dec 24, 2024
Stock price -- (ATAI: $1.19 vs. UDMY: $7.90)
Brand notoriety: ATAI and UDMY are both not notable
ATAI represents the Biotechnology, while UDMY is part of the Miscellaneous Commercial Services industry
Current volume relative to the 65-day Moving Average: ATAI: 151% vs. UDMY: 217%
Market capitalization -- ATAI: $201.36M vs. UDMY: $1.72B
ATAI [@Biotechnology] is valued at $201.36M. UDMY’s [@Miscellaneous Commercial Services] market capitalization is $1.72B. The market cap for tickers in the [@Biotechnology] industry ranges from $363.61B to $0. The market cap for tickers in the [@Miscellaneous Commercial Services] industry ranges from $80.94B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Miscellaneous Commercial Services] industry is $5.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATAI’s FA Score shows that 1 FA rating(s) are green whileUDMY’s FA Score has 0 green FA rating(s).

  • ATAI’s FA Score: 1 green, 4 red.
  • UDMY’s FA Score: 0 green, 5 red.
According to our system of comparison, UDMY is a better buy in the long-term than ATAI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATAI’s TA Score shows that 4 TA indicator(s) are bullish while UDMY’s TA Score has 4 bullish TA indicator(s).

  • ATAI’s TA Score: 4 bullish, 6 bearish.
  • UDMY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, UDMY is a better buy in the short-term than ATAI.

Price Growth

ATAI (@Biotechnology) experienced а -12.50% price change this week, while UDMY (@Miscellaneous Commercial Services) price change was -0.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.79%. For the same industry, the average monthly price growth was -2.59%, and the average quarterly price growth was +3.59%.

The average weekly price growth across all stocks in the @Miscellaneous Commercial Services industry was -1.85%. For the same industry, the average monthly price growth was -1.15%, and the average quarterly price growth was -1.26%.

Reported Earning Dates

ATAI is expected to report earnings on Mar 27, 2025.

UDMY is expected to report earnings on Feb 12, 2025.

Industries' Descriptions

@Biotechnology (-1.79% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Miscellaneous Commercial Services (-1.85% weekly)

The sector produces general business services, and are not classified elsewhere. For example, FleetCor Technologies provides fuel cards and workforce payment products and services; Copart, Inc. provides online vehicle auction and remarketing services across various nations; Equifax Inc. collects and aggregates credit information on consumers and businesses worldwide, along with selling credit monitoring and fraud-prevention services. Many of the companies in this category have multi-billion market capitalizations.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UDMY($1.72B) has a higher market cap than ATAI($201M). ATAI YTD gains are higher at: -15.603 vs. UDMY (-46.368). UDMY has higher annual earnings (EBITDA): -78.54M vs. ATAI (-124.33M). UDMY has more cash in the bank: 477M vs. ATAI (85.9M). UDMY has less debt than ATAI: UDMY (6.95M) vs ATAI (23.8M). UDMY has higher revenues than ATAI: UDMY (729M) vs ATAI (331K).
ATAIUDMYATAI / UDMY
Capitalization201M1.72B12%
EBITDA-124.33M-78.54M158%
Gain YTD-15.603-46.36834%
P/E RatioN/AN/A-
Revenue331K729M0%
Total Cash85.9M477M18%
Total Debt23.8M6.95M342%
FUNDAMENTALS RATINGS
ATAI: Fundamental Ratings
ATAI
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
81
P/E GROWTH RATING
1..100
15
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATAIUDMY
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
64%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
84%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
67%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 19 days ago
75%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 5 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 6 days ago
61%
View a ticker or compare two or three
Ad is loading...
ATAI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UDMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PICMX63.100.75
+1.20%
Virtus KAR Mid-Cap Growth I
GSVRX15.120.17
+1.14%
Goldman Sachs Large Cap Value R
NSFDX9.460.03
+0.32%
Natixis Target Retirement 2020 N
NOIGX9.780.01
+0.10%
Northern International Equity
JLCVX72.53-7.55
-9.43%
JHancock Fundamental Large Cap Core R5

ATAI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATAI has been loosely correlated with FATE. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ATAI jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATAI
1D Price
Change %
ATAI100%
N/A
FATE - ATAI
48%
Loosely correlated
+1.20%
COUR - ATAI
45%
Loosely correlated
-1.07%
VCYT - ATAI
45%
Loosely correlated
+4.66%
ALLO - ATAI
45%
Loosely correlated
+1.63%
NTLA - ATAI
45%
Loosely correlated
+0.83%
More

UDMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, UDMY has been loosely correlated with COUR. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if UDMY jumps, then COUR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UDMY
1D Price
Change %
UDMY100%
+1.80%
COUR - UDMY
38%
Loosely correlated
-1.07%
LINC - UDMY
37%
Loosely correlated
-0.06%
DNB - UDMY
37%
Loosely correlated
+1.15%
UTI - UDMY
36%
Loosely correlated
-0.51%
DLHC - UDMY
36%
Loosely correlated
+4.35%
More